Who Is This Event For?
This event is for senior biotech and pharma drug developers focussed on discovery, preclinical, translational, and clinical programs along with investors and external partnership executives focussed on aging and longevity.
Why Attend?
Attend this summit to uncover the latest developments in the age-related disease therapeutic space to explore novel strategies to target hallmarks of aging, define quantitative clinical endpoints and biomarkers, enhance translatability, and ensure clinical success.
If focussed on investment and partnerships, attend to uncover the next big thing in the aging and longevity field, stay ahead of the curve in recent novel technologies and form meaningful relationships and connections to set yourself up for commercial success.
Who Could You Meet?
This event is attended by drug developers in both the biotech and large pharma to learn about the latest technology advancements and discuss tactics to overcome the biggest challenges causing roadblocks in the field right now.
Industry investors and partnerships executives attend to keep tabs on emerging companies, novel technologies, and network with industry stakeholders.
What Do Your Peers Have To Say?
This event is attended by drug developers in both the biotech and large pharma to learn about the latest technology advancements and discuss tactics to overcome the biggest challenges causing roadblocks in the field right now.
Industry investors and partnerships executives attend to keep tabs on emerging companies, novel technologies, and network with industry stakeholders.
“Great content and networking at the cutting-edge of the topic.”
Lester Kobitz, CMO
“Interesting, exciting and promising.”
Adam Janssen, Laboratory Head
“Excellent speaker quality and presentations.”
Edward Moler, Vice President of Data Science
“Really high caliber of presenters.”
Jonathan Stein, CSO
